Current status and prospects for improved targeted delivery approaches for cancer

Sofiene Mansouri, Yousef Alharbi, Abdulrahman Alqahtani

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Millions of individuals worldwide suffer from the complicated disease known as cancer. Though they frequently have serious side effects and can harm healthy cells, the current cancer treatments, such as radiation therapy and chemotherapy, are effective in many cases. Targeted drug delivery systems have emerged as a promising new paradigm in cancer treatment because they can deliver drugs directly to cancer cells with minimal harm to healthy cells. This review aims to give a broad overview of the state of targeted drug delivery systems for cancer treatment and investigate the technology's potential in the future. We'll go through the various kinds of targeted drug delivery systems, their drawbacks, the most recent developments, and possible future paths for further study and creation. This review aims to provide an overview of the current status of targeted drug delivery systems for cancer treatment, including the different types of targeted drug delivery systems, their limitations, recent advancements, and potential future directions for research and development. By examining the field's current state and exploring prospects, this review aims to highlight the potential of targeted drug delivery systems for improving cancer treatment and ultimately enhancing patient outcomes.

Original languageEnglish
Article number154993
JournalPathology Research and Practice
Volume253
DOIs
StatePublished - Jan 2024

Keywords

  • Cancer
  • Limitation
  • Progress
  • Targeted Drug Delivery

Fingerprint

Dive into the research topics of 'Current status and prospects for improved targeted delivery approaches for cancer'. Together they form a unique fingerprint.

Cite this